PET-imaging of Two Vartumabs in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
- Status
- RECRUITING
- Phase
- PHASE3
A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Surgery and Reducing Ionizing Radiation of the Unknown Primary
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Pilot Study of MPB-2043 Enhanced MRI for Nodal Staging in Head and Neck Squamous Cell Carcinomas
- Status
- RECRUITING
- Phase
- PHASE1
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Blood Biomarkers Based Screening for HPV-driven OPC
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
- Status
- RECRUITING
- Phase
- PHASE3
A Phase II Study of Anti-EGFR Antibody-drug Conjugate (ADC) Combine With CDK4/6 Inhibitors Posterior Line in the Treatment of Recurrent/Metastatic CDKN2A Gene Variant Head and Neck Squamous Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
AK117 (Anti-CD47 mAb) Plus Cetuximab or AK104 (Anti-PD-1/CTLA-4 bsAb) as Second-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
- Status
- RECRUITING
- Phase
- PHASE3
AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer
- Status
- SUSPENDED
- Phase
- NA
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of VET3-TGI in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2